Novel Acrylate-Based Derivatives: Design, Synthesis, Antiproliferative Screening, and Docking Study as Potential Combretastatin Analogues. 2023

Eman Fayad, and Sarah Awwadh Altalhi, and Matokah M Abualnaja, and Abdulmohsen H Alrohaimi, and Fahmy G Elsaid, and Ali H Abu Almaaty, and Rasha Mohammed Saleem, and Mohammed A Bazuhair, and Ali Hassan Ahmed Maghrabi, and Botros Y Beshay, and Islam Zaki
Department of Biotechnology, College of Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.

A variety of 3-(4-chlorophenyl) acrylic acids 4a,b and 3-(4-chlorophenyl)acrylate esters 5a-i were synthesized and structurally proven by spectroscopic studies such as IR, 1H NMR, and 13C NMR as well as mass spectrometry. All substances were investigated for their antiproliferative efficacy against the MDA-MB-231 cell line. Among these, acrylic acid compound 4b demonstrated the most potent cytotoxic effect with an IC50 value of 3.24 ± 0.13 μM, as compared to CA-4 (IC50 = 1.27 ± 09 μM). Additionally, acrylic acid molecule 4b displayed an inhibitory effect against β-tubulin polymerization with a percentage inhibition of 80.07%. Furthermore, compound 4b was found to produce considerable cell cycle arrest at the G2/M stage and cellular death, as demonstrated by FACS analysis. In addition, the in vivo antitumor screening of the sodium salt of acrylic acid 4b was carried out, and the results have shown that the tested molecule showed a significant decrease in viable EAC count and EAC volume, accompanied by a considerable increase in the life span prolongation, if compared to the positive control group. Furthermore, molecular modeling studies were performed to understand how the highly efficient chemicals 4b and 5e interact with the colchicine-binding region on tubulin. This work aims to shed light on the reasons behind their exceptional cytotoxicity and their better capacity to inhibit tubulin in comparison to CA-4.

UI MeSH Term Description Entries

Related Publications

Eman Fayad, and Sarah Awwadh Altalhi, and Matokah M Abualnaja, and Abdulmohsen H Alrohaimi, and Fahmy G Elsaid, and Ali H Abu Almaaty, and Rasha Mohammed Saleem, and Mohammed A Bazuhair, and Ali Hassan Ahmed Maghrabi, and Botros Y Beshay, and Islam Zaki
January 2014, PloS one,
Eman Fayad, and Sarah Awwadh Altalhi, and Matokah M Abualnaja, and Abdulmohsen H Alrohaimi, and Fahmy G Elsaid, and Ali H Abu Almaaty, and Rasha Mohammed Saleem, and Mohammed A Bazuhair, and Ali Hassan Ahmed Maghrabi, and Botros Y Beshay, and Islam Zaki
August 2023, RSC advances,
Eman Fayad, and Sarah Awwadh Altalhi, and Matokah M Abualnaja, and Abdulmohsen H Alrohaimi, and Fahmy G Elsaid, and Ali H Abu Almaaty, and Rasha Mohammed Saleem, and Mohammed A Bazuhair, and Ali Hassan Ahmed Maghrabi, and Botros Y Beshay, and Islam Zaki
December 2017, European journal of medicinal chemistry,
Eman Fayad, and Sarah Awwadh Altalhi, and Matokah M Abualnaja, and Abdulmohsen H Alrohaimi, and Fahmy G Elsaid, and Ali H Abu Almaaty, and Rasha Mohammed Saleem, and Mohammed A Bazuhair, and Ali Hassan Ahmed Maghrabi, and Botros Y Beshay, and Islam Zaki
October 2014, Journal of enzyme inhibition and medicinal chemistry,
Eman Fayad, and Sarah Awwadh Altalhi, and Matokah M Abualnaja, and Abdulmohsen H Alrohaimi, and Fahmy G Elsaid, and Ali H Abu Almaaty, and Rasha Mohammed Saleem, and Mohammed A Bazuhair, and Ali Hassan Ahmed Maghrabi, and Botros Y Beshay, and Islam Zaki
January 2024, Molecules (Basel, Switzerland),
Eman Fayad, and Sarah Awwadh Altalhi, and Matokah M Abualnaja, and Abdulmohsen H Alrohaimi, and Fahmy G Elsaid, and Ali H Abu Almaaty, and Rasha Mohammed Saleem, and Mohammed A Bazuhair, and Ali Hassan Ahmed Maghrabi, and Botros Y Beshay, and Islam Zaki
January 2015, PloS one,
Eman Fayad, and Sarah Awwadh Altalhi, and Matokah M Abualnaja, and Abdulmohsen H Alrohaimi, and Fahmy G Elsaid, and Ali H Abu Almaaty, and Rasha Mohammed Saleem, and Mohammed A Bazuhair, and Ali Hassan Ahmed Maghrabi, and Botros Y Beshay, and Islam Zaki
January 2016, EXCLI journal,
Eman Fayad, and Sarah Awwadh Altalhi, and Matokah M Abualnaja, and Abdulmohsen H Alrohaimi, and Fahmy G Elsaid, and Ali H Abu Almaaty, and Rasha Mohammed Saleem, and Mohammed A Bazuhair, and Ali Hassan Ahmed Maghrabi, and Botros Y Beshay, and Islam Zaki
May 2012, European journal of medicinal chemistry,
Eman Fayad, and Sarah Awwadh Altalhi, and Matokah M Abualnaja, and Abdulmohsen H Alrohaimi, and Fahmy G Elsaid, and Ali H Abu Almaaty, and Rasha Mohammed Saleem, and Mohammed A Bazuhair, and Ali Hassan Ahmed Maghrabi, and Botros Y Beshay, and Islam Zaki
November 2018, Chemistry & biodiversity,
Eman Fayad, and Sarah Awwadh Altalhi, and Matokah M Abualnaja, and Abdulmohsen H Alrohaimi, and Fahmy G Elsaid, and Ali H Abu Almaaty, and Rasha Mohammed Saleem, and Mohammed A Bazuhair, and Ali Hassan Ahmed Maghrabi, and Botros Y Beshay, and Islam Zaki
September 2022, Molecules (Basel, Switzerland),
Copied contents to your clipboard!